We are live on ! Find out more
SILK

Silk Road Medical, Inc. Common Stock

Delisted

SILK was delisted on the 16th of September, 2024.

155 hedge funds and large institutions have $1.68B invested in Silk Road Medical, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 63 increasing their positions, 52 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 52

5% less capital invested

Capital invested by funds: $1.77B → $1.68B (-$88M)

10% less funds holding

Funds holding: 172155 (-17)

52% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 31

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
155
Holders Change
-17
Holders Change %
-9.88%
% of All Funds
2.7%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
15
Increased
63
Reduced
52
Closed
31
Calls
$5.4M
Puts
Net Calls
+$5.4M
Net Calls Change
+$110K
Name Holding Trade Value Shares
Change
Change in
Stake
Massachusetts Financial Services
26
Massachusetts Financial Services
Massachusetts
$13.3M -$40.3K -791 -0.3%
CIBC Asset Management
27
CIBC Asset Management
Ontario, Canada
$13.3M +$14.1M +276,857 New
Bank of America
28
Bank of America
North Carolina
$12.4M -$1.33M -26,184 -9%
Ensign Peak Advisors
29
Ensign Peak Advisors
Utah
$12.2M -$5.49M -107,733 -30%
Charles Schwab
30
Charles Schwab
California
$11.3M +$900K +17,660 +8%
Jennison Associates
31
Jennison Associates
New York
$10.5M -$7.35M -144,200 -40%
ZCM
32
Ziegler Capital Management
Illinois
$7.79M -$2.38M -46,678 -41%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$7.74M +$2.67M +52,339 +48%
N
34
Nuveen
North Carolina
$7.4M +$874K +17,159 +12%
Wells Fargo
35
Wells Fargo
California
$7.14M -$1.11M -21,752 -13%
NHAS
36
Novo Holdings A/S
Denmark
$7.06M
PA
37
Perceptive Advisors
New York
$7.04M -$9.83M -192,967 -57%
RPAM
38
Rhenman & Partners Asset Management
Sweden
$6.99M
Neuberger Berman Group
39
Neuberger Berman Group
New York
$6.43M +$276K +5,410 +4%
Morgan Stanley
40
Morgan Stanley
New York
$5.26M -$1.41M -27,754 -20%
State of Wisconsin Investment Board
41
State of Wisconsin Investment Board
Wisconsin
$5.21M
FAM
42
Fred Alger Management
New York
$4.73M -$7.47M -146,616 -60%
Two Sigma Investments
43
Two Sigma Investments
New York
$4.59M -$10.2M -199,615 -68%
SBH
44
Segall Bryant & Hamill
Illinois
$4.46M +$284K +5,566 +6%
JP Morgan Chase
45
JP Morgan Chase
New York
$4.08M -$654K -12,842 -13%
Asset Management One
46
Asset Management One
Japan
$3.92M +$274K +5,370 +7%
MOACM
47
Mutual of America Capital Management
New York
$3.73M +$1.19M +23,397 +43%
Macquarie Group
48
Macquarie Group
Australia
$3.55M +$638K +12,531 +20%
GKIM
49
GW&K Investment Management
Massachusetts
$3.53M
Citadel Advisors
50
Citadel Advisors
Florida
$3.52M -$143K -2,799 -4%

SILK Hedge Fund Activity: Q2 2021 in Review

155 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q2 2021, worth a combined $1.68B — down 5% from $1.77B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of SILK and 15 opened new positions — a net loss of 16 holders — while 52 trimmed existing stakes and 63 added.

The largest buyer was Capital World Investors, adding an estimated $34.3M. The largest seller was BlackRock, cutting an estimated $31.7M.

  • 155 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q2 2021, down from 172 in Q1 2021.
  • Funds reported $1.68B of Silk Road Medical, Inc. Common Stock stock for Q2 2021, down 5% quarter-over-quarter.
  • 15 funds opened new Silk Road Medical, Inc. Common Stock positions in Q2 2021 and 31 closed out, a net change of -16 holders.
  • The largest Silk Road Medical, Inc. Common Stock buyer in Q2 2021 was Capital World Investors, an estimated $34.3M added.
  • The largest Silk Road Medical, Inc. Common Stock seller in Q2 2021 was BlackRock, an estimated $31.7M sold.

Based on aggregated 13F filings for Q2 2021.